Introduction
• The Cancer Care Ontario (CCO) Program in Evidence-based Care (PEBC) and the American Society of Clinical Oncology (ASCO) convened an expert panel in August 2006 to review the evidence and draft recommendations on the role of adjuvant chemotherapy and adjuvant radiation therapy for completely resected stages I-IIIA non-small cell lung cancer (NSCLC).
• CCO originally published guidelines in 1997 and updated them in 2004-2006. • Both CCO-PEBC and ASCO conducted external reviews of the current guidelines. • Stage IIIA: Adjuvant radiation therapy is not recommended for routine use because of the lack of prospective, randomized clinical trial data evaluating its efficacy. A clinical trial is underway to determine the advisability of its routine use.
Recommendations apply only to completely resected tumors. • With the physician providing immediate guidance and interpretation, a graph may help patients achieve a better understanding of absolute risk and benefit.
• Graphical Representations* The figures are a graphical representation of patient survival probabilities at 5 years: the combined yellow and green areas represents the survival probability for the treatment group (S a ) (the yellow represents the survival probability for untreated patients (S c ), green represents the absolute risk reduction (S a -S c ), i.e., the "extra" survival achieved by therapy), the white area represent the mortality probability in patients (1-S a ). The statistical uncertainty in these probabilities is not depicted in the figures. Calculations for these figures included data on untreated patients from the ANITA trial because these data were not available in the LACE abstract. *Includes the three trials that included only stage IB, does not include two trials open for stages IA and IB.
Selective Review of Molecular Markers in NSCLC
• Panel undertook selective review of the literature pertaining to seven molecular markers 
ASCO Guidelines
It is im p o rta n t to re a lize th a t m a n y m a n a g e m e n t q u e stio n s h a ve n o t b e e n c o m p re h e n s ive ly a d d re s s e d in ra n d o m ize d tria ls a n d g u id e lin e s ca n n o t a lw a ys a c c o u n t fo r in d ivid u a l va ria tio n a m o n g p a tie n ts . A g u id e lin e is n o t in te n d e d to s u p p la n t p h ys ic ia n ju d g m e n t w ith re s p e ct to p a rtic u la r p a tie n ts o r sp e c ia l c lin ic a l s itu a tio n s a n d c a n n o t b e c o n s id e re d in c lu s ive o f a ll p ro p e r m e th o d s o f c a re o r e xc lu s ive o f o th e r tre a tm e n ts re a so n a b ly d ire c te d a t o b ta in in g th e sa m e re s u lts . A c c o rd in g ly, A S C O c o n s id e rs a d h e re n c e to th is g u id e lin e to b e vo lu n ta ry, w ith th e u ltim a te d e te rm in a tio n re g a rd in g its a p p lic a tio n to b e m a d e b y th e p h ys ic ia n in lig h t o f e a c h p a tie n t's in d ivid u a l c irc u m s ta n c e s . In a d d itio n , th e gu id e lin e d e s c rib e s a d m in is tra tio n o f th e ra p ie s in c lin ic a l p ra c tic e ; it ca n n o t b e a s s u m e d to a p p ly to in te rve n tio n s p e rfo rm e d in th e c o n te xt o f c lin ic a l tria ls , g ive n th a t c lin ic a l s tu d ie s a re d e s ig n e d to te s t in n o va tive a n d n o ve l th e ra p ie s in a d is e a s e a n d s e ttin g fo r w h ic h b e tte r th e ra p y is n e e d e d . B e c a u se g u id e lin e d e ve lo p m e n t in vo lve s a re vie w a n d s yn th e s is o f th e la te s t lite ra tu re , a p ra c tic e g u id e lin e a ls o s e rve s to id e n tify im p o rta n t q u e s tio n s fo r fu rth e r re s e a rc h a n d th o se s e ttin g s in w h ic h in ve s tig a tio n a l th e ra p y s h o u ld b e c o n sid e re d .
